Evaluation of Factors Associated With Elevated Levels of Platelet-Derived Microparticles in the Acute Phase of Cerebral Infarction

Abstract

Background: Platelet-derived microparticles (PDMPs) have attracted attention as blood coagulation-promoting, endothelial cell-activating factors. The objective of this study was to determine the parameters associated with elevated PDMP levels and examine their relationship with atherosclerotic lesions of main intracranial and extracranial arteries. Participants and Methods: Participants included a control group (C) of 61 patients with no apparent cerebral vascular lesions and 110 patients with acute-phase cerebral infarction, consisting of a small-vessel occlusion group (S) of 34 patients, a large-artery atherosclerosis group (L) of 41 patients, a cardioembolism group (CE) of 20 patients, and a stroke of undetermined etiology group (U) of 15 patients. Platelet-derived microparticle levels were measured using enzyme-linked immunosorbent assay (ELISA) at the time of admission, and the patients were reclassified into group CP (control level PDMPs), consisting of 70 patients with control PDMP levels, and group HP (high PDMPs), consisting of 40 patients with elevated PDMP levels. All patients underwent cranial magnetic resonance (MR) and carotid ultrasound examinations. Results: Platelet-derived microparticle levels were significantly higher in groups S and L than in group C (P < .01). Concomitant intima-media thickness (IMT; odds ratio [OR] = 1.29, P < .05) and concomitant intracranial stenosis (OR = 3.95, P < .01) were significantly correlated with elevated PDMP levels. Fibrinogen and high-sensitivity CRP levels were significantly higher in group HP than in group CP. Conclusion: Alterations in PDMP levels correlated with the presence of atherothrombotic lesions, and PDMP levels are expected to be useful as a clinical indicator, reflecting the presence of intracranial atherosclerotic lesions in the acute phase of cerebral infarction.

Keywords

platelet-derived microparticle cerebral infarction intracranial atherosclerosis inflammatory activation

References

Shattil SJ , Cunningham M. , Hoxie JA Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood. 1987;70(1):307-315.

Sims PJ , Faioni EM , Wiedmer T. , Shattil SJ , et al. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem . 1988;263(34): 18205-18212.

Sims KD , Straff DJ , Robinson MB Platelet-derived growth factor rapidly increases activity and cell surface expression of the EAAC1 subtype of glutamate transporter through activation of phosphatidylinositol 3-kinase. J Biol Chem. 2000;275(7):5228-5237.

Nomura S. Function and clinical significance of platelet-derived microparticles . Int J Hematol. 2001;74(4): 397-404.

Osumi K. , Ozeki Y. , Saito S. , et al. Development and assessment of enzyme immunoassay for platelet-derived microparticles. Thromb Haemost. 2001;85(2):326-330.

Adams HP Jr , Bendixen BH , Kappelle LJ , et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke . 1993;24(1):35-41.

North American Symptomatic Carotid Endarterectomy Trial. Methods, patient characteristics, and progress. Stroke. 1991;22(6):711-720.

Ho CH , Hu HH , Wong WJ The serial hemostasis-related changes in patients with cerebral infarction: comparison between progressing and non-progressing stroke. Thromb Res. 1989;56(5):635-647.

Htun P. , Fateh-Moghadam S. , Tomandl B. , et al. Course of platelet activation and platelet-leukocyte interaction in cerebrovascular ischemia. Stroke. 2006;37(9):2283-2287.

10.

Nomura S. , Uehata S. , Saito S. , Osumi K. , Ozeki Y. , Kimura Y. , et al. Enzyme immunoassay detection of platelet-derived microparticles and RANTES in acute coronary syndrome. Thromb Haemost. 2003;89(3): 506-512.

11.

Nomura S. , Imamura A. , Okuno M. , et al. Platelet-derived microparticles in patients with arteriosclerosis obliterans: enhancement of high shear-induced microparticle generation by cytokines. Thromb Res. 2000;98(4): 257-268.

12.

Nomura S. , Takahashi N. , Inami N. , et al. Probucol and ticlopidine: effect on platelet and monocyte activation markers in hyperlipidemic patients with and without type 2 diabetes. Atherosclerosis. 2004;174(2):329-335.

13.

Inami N. , Nomura S. , Kikuchi H. , et al. P-selectin and platelet-derived microparticles associated with monocyte activation markers in patients with pulmonary embolism. Clin Appl Thromb Hemost. 2003;9(4): 309-316.

14.

Matsumoto N. , Nomura S. , Kamihata H. , Kimura Y. , Iwasaka T. Increased level of oxidized LDL-dependent monocyte-derived microparticles in acute coronary syndrome. Thromb Haemost. 2004;91(1):146-154.

15.

Lee YJ , Jy W. , Horstman LL , et al. Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. Thromb Res. 1993;72(4):295-304.

16.

Simak J. , Gelderman MP , Yu H. , et al. Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome. J Thromb Haemost . 2006;4(6):1296-1302.

17.

Williams JB , Jauch EC , Lindsell CJ , et al. Endothelial microparticle levels are similar in acute ischemic stroke and stroke mimics due to activation and not apoptosis/ necrosis. Acad Emerg Med. 2007;14(8):685-690.

18.

Nomura S. , Tandon NN , Nakamura T. , Cone J. , Fukuhara S. , Kambayashi J. High-shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells . Atherosclerosis. 2001;158(2):277-287.

19.

Barry OP , Pratico D. , Savani RC , FitzGerald GA Modulation of monocyte-endothelial cell interactions by platelet microparticles . J Clin Invest. 1998;102(1):136-144.